NCT07229586 2025-12-19
A Study of SHR-7367 With Anti-tumor Agents in Patients With Solid Tumors
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 1/2 Recruiting
Shanghai Hengrui Pharmaceutical Co., Ltd.
Huabo Biopharm Co., Ltd.
Hoffmann-La Roche
Genentech, Inc.